Anika Therapeutics, Inc. (ANIK) stock
ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
$12.85−0.07 (-0.54%)
Close on Nov 17, 2026Market cap $171.97MP/E –Yield –
Anika Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Anika Therapeutics's enterprise value was $148.28M on Nov 11, 2026, against $62.30M a year earlier. Over the last 5 years it ranged from $42.99M to $426.27M, with a median of $215.36M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $148.28M | +153.9% |
| 2025 | Dec 31, 2025 | $58.41M | -61.4% |
| 2024 | Dec 31, 2024 | $151.14M | -33.2% |
| 2023 | Dec 29, 2023 | $226.34M | -27.1% |
| 2022 | Dec 30, 2022 | $310.42M | -27.2% |
| 2021 | Dec 31, 2021 | $426.27M | -21.5% |
| 2020 | Dec 31, 2020 | $543.30M | -4.1% |
| 2019 | Dec 31, 2019 | $566.64M | +72.4% |
| 2018 | Dec 31, 2018 | $328.62M | -48.5% |
| 2017 | Dec 29, 2017 | $637.72M | +7.1% |
| 2016 | Dec 30, 2016 | $595.65M | +34.7% |
| 2015 | Dec 31, 2015 | $442.36M | -13.5% |
| 2014 | Dec 31, 2014 | $511.20M | +4.6% |
| 2013 | Dec 31, 2013 | $488.74M | +355.2% |
| 2012 | Dec 31, 2012 | $107.37M | -7.5% |
| 2011 | Dec 30, 2011 | $116.05M | +120.2% |
| 2010 | Dec 31, 2010 | $52.69M | – |
See a number that looks wrong?